Tech Company Financing Transactions
ArgiNOx Pharmaceuticals Funding Round
ArgiNOx Pharmaceuticals, operating out of Redwood City, secured $25 million in investment from Topspin Partners.
Transaction Overview
Company Name
Announced On
3/1/2005
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Topspin Partners (Lead Investor)
Proceeds Purpose
This financing will enable Arginox to advance our product development efforts in two important ways, said Kenneth Drazan, M.D., the company's chief executive officer.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3 Lagoon Dr. 220
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Not Recorded
Overview
Arginox Pharmaceuticals is an emerging specialty biopharmaceutical company focusing on the discovery and development of breakthrough drugs for treating hospitalized patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Drazan
Browse more venture capital transactions:
Prev: 3/1/2005: Frontier Silicon Limited venture capital transaction
Next: 3/1/2005: Brightcove venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs